Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
NCT Number: NCT06337279
The Systemic Oxidative Stress Score (SOSS) , a comprehensive score reflecting the oxidative stress conditions in the microenvironment, can independently and effectively predict tumor burden and long-term prognosis in GC patients. Nomograms based on SOSS provide a potential and promising model for risk stratification and guiding the implementation of treatment decisions.
Looking for future studies?
Notify MeAll sexes
Observational
Fuzhou, Fujian, 350000, China
We retrospectively analyzed the clinical data of gastric cancer patients who underwent radical gastrectomy in three hospitals from January 2009 to June 2020. The data from one hospital were randomly divided into a training cohort and an internal validation cohort in a 7:3 ratio, while the data from the other two centers were used as an external validation cohort. In the training cohort, COX proportional risk models were employed to identify key indicators of SOSS and independent prognostic factors influencing patients' OS and DFS. Subsequently, based on the results of the multifactor COX analysis, two predictive models for OS and DFS were developed. The predictive efficacy, calibration, and clinical utility of the models were evaluated using ROC curves, calibration curves, and decision curves in the internal and external validation cohorts, respectively. Both models demonstrated good discriminative ability between postoperative survival and recurrence risk, outperforming TNM staging in terms of predictive accuracy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years or 60 months
Overall survival, death, survival with tumor, deletion.
Time frame: 5 years or 60 months
Disease-free survival, death,recurrence
Fujian Medical University
Other
The Clinical Value of Systemic Oxidative Stress Score in Predicting Long-term Survival and Recurrence Risk in Gastric Cancer: A Multicenter Real-world Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01364493
Digestive System Diseases, Digestive System Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT01441310
Digestive System Diseases, Digestive System Neoplasms
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT07683195
Digestive System Diseases, Digestive System Neoplasms
Jinan, Shandong, China
View Trial DetailsNCT07243015
Digestive System Diseases, Digestive System Neoplasms
Duarte, California, United States
View Trial Details